Home > Annual Financials > FERMENTA BIOTECH

FERMENTA BIOTECH Financial Statement Analysis
[BOM: 506414]

The Revenues of FERMENTA BIOTECH have decreased by -12.19% YoY .
The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

FERMENTA BIOTECH Last 5 Annual Financial Results
[BOM: 506414]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹350 Cr₹399 Cr₹377 Cr₹293 Cr₹405 Cr
Expenses ₹331 Cr₹336 Cr₹295 Cr₹229 Cr₹269 Cr
Operating Profit (Excl OI) ₹19 Cr₹62 Cr₹83 Cr₹64 Cr₹135 Cr
Other Income ₹7.69 Cr₹8.25 Cr₹8.37 Cr₹14 Cr₹27 Cr
Interest ₹21 Cr₹18 Cr₹19 Cr₹20 Cr₹21 Cr
Depreciation ₹28 Cr₹26 Cr₹20 Cr₹15 Cr₹12 Cr
Profit Before Tax ₹-52 Cr₹27 Cr₹52 Cr₹43 Cr₹129 Cr
Profit After Tax ₹-54 Cr₹15 Cr₹43 Cr₹60 Cr₹118 Cr
Consolidated Net Profit ₹-51 Cr₹15 Cr₹46 Cr₹60 Cr₹117 Cr
Earnings Per Share (Rs)₹-17.85₹5.35₹15.77₹20.63₹128.05
PAT Margin (%)-15.303.7811.2720.3229.14
ROE(%)-16.264.2713.0521.9264.77
ROCE(%)-5.357.5012.6212.9840.16
Total Debt/Equity(x)0.720.660.660.730.87

Key Financials

Market Cap : ₹ 506.7 Cr
Revenue (TTM) : ₹ 343.5 Cr
Net Profit(TTM) : ₹ -21.8 Cr
EPS (TTM) : ₹ -7.4
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
FERMENTA BIOTECH -2.2% -23.9% 14.6%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%


FERMENTA BIOTECH Revenues
[BOM: 506414]

Y-o-Y

-12.19 %

5 Yr CAGR

-3.57 %

Years Revenues % Change
Mar2023 ₹350 Cr
-12.19
Mar2022 ₹399 Cr
5.63
Mar2021 ₹377 Cr
28.79
Mar2020 ₹293 Cr
-27.61
Mar2019 ₹405 Cr -


FERMENTA BIOTECH Operating Profit
[BOM: 506414]

Y-o-Y

-70.23 %

5 Yr CAGR

-39.17 %

Years Operating Profit % Change
Mar2023 ₹19 Cr
-70.23
Mar2022 ₹62 Cr
-24.64
Mar2021 ₹83 Cr
28.41
Mar2020 ₹64 Cr
-52.48
Mar2019 ₹135 Cr -

Operating Margins
Y-o-Y

-66.13 %

5 Yr CAGR

-36.93 %

Years Operating Margin% % Change
Mar2023 5.29%
-66.13
Mar2022 15.62%
-28.64
Mar2021 21.89%
-0.27
Mar2020 21.95%
-34.36
Mar2019 33.44% -

FERMENTA BIOTECH Profit After Tax
[BOM: 506414]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2023 ₹-51 Cr
Negative
Mar2022 ₹15 Cr
-66.06
Mar2021 ₹46 Cr
-23.55
Mar2020 ₹60 Cr
-49.32
Mar2019 ₹117 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2023 -15.3 %
Negative
Mar2022 3.78 %
-66.46
Mar2021 11.27 %
-44.54
Mar2020 20.32 %
-30.27
Mar2019 29.14 % -

FERMENTA BIOTECH Earnings Per Share (EPS)
[BOM: 506414]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2023 ₹-18
Negative
Mar2022 ₹5.35
-66.07
Mar2021 ₹16
-23.56
Mar2020 ₹21
-83.89
Mar2019 ₹128 -

FERMENTA BIOTECH Return on Capital Employed (ROCE)
[BOM: 506414]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2023 -5.35%
Negative
Mar2022 7.5%
-40.57
Mar2021 12.62%
-2.77
Mar2020 12.98%
-67.68
Mar2019 40.16% -

FERMENTA BIOTECH Share Price vs Sensex

Current Share Price : ₹172.4
Current MarketCap: ₹ 506.7 Cr
Updated EOD on :Apr 22,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
FERMENTA BIOTECH

-2.2%

-23.9%

14.6%

SENSEX

-0.8%

1.4%

22.9%

FERMENTA BIOTECH related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about FERMENTA BIOTECH Financials


How the annual revenues of FERMENTA BIOTECH have changed ?

The Revenues of FERMENTA BIOTECH have decreased by -12.19% YoY .

How the Earnings per Share (EPS) of FERMENTA BIOTECH have changed?

The Earnings Per Share (EPS) of FERMENTA BIOTECH has decreased by Negative YoY .